Insider Transactions in Q4 2023 at Eli Lilly & CO (LLY)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 18
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.16%
|
$14,475
$579.76 P/Share
|
Dec 18
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.43%
|
$5,211
$579.76 P/Share
|
Dec 18
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.02%
|
$9,843
$579.76 P/Share
|
Dec 18
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.18%
|
$9,843
$579.76 P/Share
|
Dec 18
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.66%
|
$9,843
$579.76 P/Share
|
Dec 18
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.04%
|
$11,580
$579.76 P/Share
|
Dec 01
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,142
-22.5%
|
$1,265,922
$591.04 P/Share
|
Dec 01
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,810
+33.57%
|
-
|
Nov 20
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
354
+0.33%
|
$211,338
$597.6 P/Share
|
Nov 20
2023
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+1.57%
|
$199,995
$597.6 P/Share
|
Nov 20
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+7.23%
|
$204,771
$597.6 P/Share
|
Nov 20
2023
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+5.37%
|
$199,995
$597.6 P/Share
|
Nov 20
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
351
+6.17%
|
$209,547
$597.6 P/Share
|
Nov 20
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
359
+1.14%
|
$214,323
$597.6 P/Share
|
Nov 20
2023
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+1.98%
|
$199,995
$597.6 P/Share
|
Nov 20
2023
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+1.46%
|
$199,995
$597.6 P/Share
|
Nov 20
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
352
+0.24%
|
$210,144
$597.6 P/Share
|
Nov 20
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
352
+10.42%
|
$210,144
$597.6 P/Share
|
Nov 20
2023
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+3.67%
|
$199,995
$597.6 P/Share
|
Nov 14
2023
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
15,000
-3.41%
|
-
|
Nov 10
2023
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Bona fide gift
|
Direct |
17
-0.02%
|
-
|
Nov 06
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
670
-12.46%
|
$382,570
$571.1 P/Share
|
Oct 16
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.46%
|
$4,928
$616.64 P/Share
|
Oct 16
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.5%
|
$9,856
$616.64 P/Share
|
Oct 16
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.72%
|
$9,856
$616.64 P/Share
|
Oct 16
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.15%
|
$14,168
$616.64 P/Share
|
Oct 16
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.03%
|
$11,088
$616.64 P/Share
|
Oct 16
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.02%
|
$9,856
$616.64 P/Share
|
Oct 11
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
215,000
-0.04%
|
$130,075,000
$605.51 P/Share
|